Shares of None company Natera climbed 4.5% this evening. Here are some quick facts to get you started if you are interested in the stock:
-
Natera has logged a 40.0% 52 week change, compared to 14.0% for the S&P 500
-
NTRA has an average analyst rating of buy and is -18.66% away from its mean target price of $71.87 per share
-
Its trailing earnings per share (EPS) is $-4.51, which brings its trailing Price to Earnings (P/E) ratio to -13.0. The Health Care sector's average P/E ratio is None
-
The company's forward earnings per share (EPS) is $-2.66 and its forward P/E ratio is -22.0
-
The company has a Price to Book (P/B) ratio of 8.87 in contrast to the Health Care sector's average P/B ratio is None
-
The company's free cash flow for the last fiscal year was $-311451000 and the average free cash flow growth rate is -39.6%
-
Natera's revenues have an average growth rate of 25.1% with operating expenses growing at None%. The company's current operating margins stand at -50.4%